Erratum: MiR-30a-5p Suppresses Cell Growth and Enhances Apoptosis of Hepatocellular Carcinoma Cells Via Targeting AEG-1.

Rui-Wen He,Lu Yang,Xiao Lin,Xuesong Chen,Fuxiang Wei,Xin Liang,Yunping Luo,Yi Wu,Gan T,Yi‐Wu Dang,G Chen

2020-01-01

Abstract:[This corrects the article on p. 15632 in vol. 8, PMID: 26884832.].

What problem does this paper attempt to address?

Mir-148b Suppresses Cell Proliferation And Invasion In Hepatocellular Carcinoma By Targeting Wnt1/Beta-Catenin Pathway (Vol 5, 8087, 2015)

Jun-gang Zhang,Ying Shi,De-fei Hong,Mengqi Song,Dongsheng Huang,Chun-you Wang,Gang Zhao

DOI: https://doi.org/10.1038/srep46886

IF: 4.6

2017-01-01

Scientific Reports

Abstract:[This corrects the article DOI: 10.1038/srep08087.].
Erratum: miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro .

Conglin Ye,Xiaolong Yu,Xuqiang Liu,Min Dai,Bin Zhang

DOI: https://doi.org/10.3892/ol.2020.12394

2021-01-01

Oncology Letters

Abstract:[This corrects the article DOI: 10.3892/ol.2018.7900.].
[Corrigendum] MicroRNA‑92a Contributes to Tumor Growth of Human Hepatocellular Carcinoma by Targeting FBXW7

Wei Yang,Changwei Dou,Yufeng Wang,Yuli Jia,Chao Li,Xin Zheng,Kangsheng Tu

DOI: https://doi.org/10.3892/or.2023.8596

2023-01-01

Oncology Reports

Abstract:Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that certain of the control western blotting data featured in Fig. 5 on p. 2581 had also appeared in a couple of other articles featuring several of the same authors [Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y and Liu Q: Fibulin‑5 inhibits hepatocellular carcinoma cell migration and invasion by down‑regulating matrix metalloproteinase‑7 expression. BMC Cancer 14: 938, 2014; and Gai X, Tu K, Li C, Roberts LR and Zheng X: Histone acetyltransferase PCAF accelerates apoptosis by repressing a GLI1/BCL2/BAX axis in hepatocellular carcinoma. Cell Death Dis 6: e1712, 2015]. In addition, the authors drew to the attention of the Editorial Office that a couple of mistakes were made during the assembly of Fig. 2D on p. 2579. The authors were able to re-examine their original data files, and realized that these figures had been inadvertently assembled incorrectly (they were also able to present the raw data from which these figures had been assembled to the Editorial Office). The revised versions of Figs. 2 and 5, containing the intended flow cytometric and western blotting data for these figures respectively, is shown on the next page. The authors wish to emphasize that the corrections made to these figures do not affect the overall conclusions reported in the paper, and they are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this corrigendum. All the authors agree to the publication of this corrigendum, and also apologize to the readership for any inconvenience caused. [Oncology Reports 34: 2576‑2584, 2015; DOI: 10.3892/or.2015.4210].
Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.

Peijie Chen,Jing Quan,Lu Jin,Canbin Lin,Weijie Xu,Jinling Xu,Xin Guan,Zebo Chen,Liangchao Ni,Shangqi Yang,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/etm.2024.12443

IF: 2.7

2024-01-01

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.5881.].
Correction to: Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro

Minhua Rong,Gang Chen,Yiwu Dang

DOI: https://doi.org/10.1186/s12885-020-6680-3

IF: 4.638

2020-01-01

BMC Cancer

Abstract:Following publication of the original article [1], the authors reported that they had misspelt the name of a cell line and supplied the incorrect Fig. 7 for publication.
Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Jing Zheng,Tao Xu,Feng Chen,Ying Zhang

DOI: https://doi.org/10.1007/s12253-020-00794-3

2020-01-01

Abstract:The original version of this article unfortunately contained an error in the affiliation section.
Erratum: CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum.

Yan-Ming Liu,Yue Cao,Ping-Sen Zhao,Liang-Yin Wu,Ya-Min Lu,Yu-Long Wang,Jia-Feng Zhao,Xin-Guang Liu

DOI: https://doi.org/10.7150/ijbs.72651

2022-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.66915.].
Retraction Notice To: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells

Yunhao Chen,Hui Zhao,Haibo Li,Xiao Feng,Hui Tang,Chunhui Qiu,Jianwen Zhang,Binsheng Fu

DOI: https://doi.org/10.1016/j.omtn.2019.10.035

IF: 10.183

2019-01-01

Molecular Therapy — Nucleic Acids

Abstract:[This retracts the article DOI: 10.1016/j.omtn.2019.10.035.].
Erratum: Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis: Erratum.

Zunqiang Xiao,Yang Liu,Junjun Zhao,Lijie Li,Linjun Hu,Qiliang Lu,Zhi Zeng,Xin Liu,Dongsheng Huang,Wei Yang,Qiuran Xu

DOI: https://doi.org/10.7150/ijbs.61130

2021-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.45457.].
[Corrigendum] miR‐216a‐5p acts as an oncogene in renal cell carcinoma

Peijie Chen,Jing Quan,Lu Jin,Canbin Lin,Weijie Xu,Jinling Xu,Xin Guan,Zebo Chen,Liangchao Ni,Shangqi Yang,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/etm.2024.12443

IF: 2.7

2024-02-21

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.5881.].

medicine, research & experimental
Erratum: miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis

Yingxue Wang,Aiying Cen,Yuxian Yang,Huilin Ye,Jiaying Li,Shiliang Liu,Lei Zhao

DOI: https://doi.org/10.1016/j.omtn.2024.102239

2024-06-07

Abstract:[This corrects the article DOI: 10.1016/j.omtn.2021.02.027.].
The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum

Liu Yang,Yang Guo,Xin Liu,Tongtong Wang,Xiangmin Tong,Kefeng Lei,Jiahui Wang,Dongsheng Huang,Qiuran Xu

DOI: https://doi.org/10.7150/jca.76866

IF: 3.9

2022-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.25569.].

oncology
Corrigendum: MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4

Yi-Fei Wang,Xiang Ao,Ying Liu,Dan Ding,Wen-Jie Jiao,Zhuang Yu,Wen-Xin Zhai,Sheng-Hua Dong,Yu-Qi He,Hang Guo,Jian-Xun Wang

DOI: https://doi.org/10.3389/fgene.2021.649586

IF: 3.7

2021-03-30

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2019.00809.].

genetics & heredity
Correction: Chao Et Al. MicroRNA-22-3p and MicroRNA-149-5p Inhibit Human Hepatocellular Carcinoma Cell Growth and Metastasis Properties by Regulating Methylenetetrahydrofolate Reductase. Curr. Issues Mol. Biol. 2022, 44, 952–962

Chao Li,Xiang Li,Han Wang,Xihan Guo,Jinglun Xue,Xu Wang,Juan Ni

DOI: https://doi.org/10.3390/cimb46090630

2024-01-01

Current Issues in Molecular Biology

Abstract:Author Correction: We apologize for unintentionally using the wrong figures (Figure 5b and Figure 6e) in the original article [...]
[Corrigendum] Propofol‐induced HOXA11‐AS promotes proliferation, migration and invasion, but inhibits apoptosis in hepatocellular carcinoma cells by targeting miR‐4458

Furong Song,Jun Liu,Yawei Feng,Yi Jin

DOI: https://doi.org/10.3892/ijmm.2024.5351

IF: 5.314

2024-01-22

International Journal of Molecular Medicine

Abstract:Following the publication of the above article, an interested reader drew to the authors' attention that the western blots for the PCNA and cyclin D1 bands appeared to be strikingly similar. The authors were able to re‑examine their original data, and recognize how the error was made with respect to the compilation of this figure (they were also able to demonstrate to the Editorial Office how the error occurred). The revised version of Fig. 3, now incorporating the correct data for the PCNA bands in Fig. 3A, is shown on the next page. The authors can confirm that the errors associated with this figure did not have a significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of <i>International Journal of Molecular Medicine</i> for allowing them the opportunity to publish this Corrigendum; furthermore, they apologize to the readership of the Journal for any inconvenience caused. [International Journal of Molecular Medicine 46: 1135‑1145, 2020; DOI: 10.3892/ijmm.2020.4667].

medicine, research & experimental
Erratum: KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p: Erratum.

Mimi Zhou,Jinqiu Chen,Hui Zhang,Hailing Liu,Huan Yao,Xiaman Wang,Wanggang Zhang,Yingren Zhao,Nan Yang

DOI: https://doi.org/10.7150/ijbs.77067

2022-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.45999.].
[Corrigendum] microRNA‐181a‐5p functions as an oncogene in renal cell carcinoma

Yulin Lai,Liwen Zhao,Jia Hu,Jing Quan,Peijie Chen,Jinling Xu,Xin Guan,Yongqing Lai,Liangchao Ni

DOI: https://doi.org/10.3892/mmr.2024.13182

IF: 3.423

2024-02-16

Molecular Medicine Reports

Abstract:Following the publication of the above article and a corrigendum in 2018 that corrected details of the correspondence information for authors, errors made in Fig. 5 and the funding details (doi: 10.3892/mmr.2018.9117), an interested reader drew to the authors' attention that, in Fig. 6 on p. 8515 showing the results of cell migration and invasion assay experiments, a pair of data panels were overlapping, such that data which were intended to show the results from differently performed experiments appeared to have been derived from the same original source. After having consulted their original data, the authors have realized that Fig. 6 was assembled incorrectly, The revised version of Fig. 6, now showing the correct data for the 'ACHN/migratory/NC' experiment, is shown on the next page. Note that all the authors approve of the publication of this corrigendum, and the authors are grateful to the Editor of Molecular Medicine Reports for granting them the opportunity to publish this. The authors regret their oversight in allowing this error to be included in the paper, and also apologize to the readership for any inconvenience caused. [Molecular Medicine Reports 17: 8510‐8517, 2018; DOI: 10.3892/mmr.2018.8899]

oncology,medicine, research & experimental
Retraction: MicroRNA-142-5p Overexpression Inhibits Cell Growth and Induces Apoptosis by Regulating FOXO in Hepatocellular Carcinoma Cells

Oncology Research Editorial Office

DOI: https://doi.org/10.32604/or.2024.056123

2024-08-23

Abstract:[This retracts the article DOI: 10.3727/096504016X14719078133366.].
MiR-30e Suppresses Proliferation of Hepatoma Cells Via Targeting Prolyl 4-Hydroxylase Subunit Alpha-1 (P4HA1) Mrna

Guoxing Feng,Hui Shi,Jiong Li,Zhe Yang,Runping Fang,Lihong Ye,Weiying Zhang,Xiaodong Zhang

DOI: https://doi.org/10.1016/j.bbrc.2016.03.008

IF: 3.1

2016-01-01

Biochemical and Biophysical Research Communications

Abstract:Aberrant microRNA expression has been shown to be characteristic of many cancers. It has been reported that the expression levels of miR-30e are decreased in liver cancer tissues. However, the role of miR-30e in hepatocellular carcinoma remains poorly understood. In the present study, we investigated the significance of miR-30e in hepatocarcinogenesis. Bioinformatics analysis reveals a putative target site of miR-30e in the 3'-untranslated region (3'UTR) of prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA. Moreover, luciferase reporter gene assays verified that miR-30e directly targeted 3'UTR of P4HA1 mRNA. Then, we demonstrated that miR-30e was able to reduce the expression of P4HA1 at the levels of mRNA and protein using reverse transcription-polymerase chain reaction and Western blot analysis. Enforced expression of miR-30e suppressed proliferation of HepG2 cells by 5-ethynyl-2-deoxyuridine (EdU) assay and reduced colony formation of these cells by colony formation analysis. Conversely, anti-miR-30e enhanced the proliferation of hepatoma cells in vitro. Interestingly, the ectopic expression of P4HA1 could efficiently rescue the inhibition of cell proliferation mediated by miR-30e in HepG2 cells. Meanwhile, silencing of P4HA1 abolished the anti-miR-30e-induced proliferation of cells. Clinically, quantitative real-time PCR showed that miR-30e was down-regulated in liver tumor tissues relative to their peritumor tissues. The expression levels of miR-30e were negatively correlated to those of P4HA1 mRNA in clinical liver tumor tissues. Thus, we conclude that miR-30e suppresses proliferation of hepatoma cells through targeting P4HA1 mRNA. Our finding provides new insights into the mechanism of hepatocarcinogenesis. (C) 2016 Elsevier Inc. All rights reserved.
[Corrigendum] miR‐199b‐5p serves as a tumor suppressor in renal cell carcinoma

Yulin Lai,Jing Quan,Canbin Lin,Hang Li,Jia Hu,Peijie Chen,Jinling Xu,Xin Guan,Weijie Xu,Yongqing Lai,Liangchao Ni

DOI: https://doi.org/10.3892/etm.2024.12422

IF: 2.7

2024-02-09

Experimental and Therapeutic Medicine

Abstract:[This corrects the article DOI: 10.3892/etm.2018.6151.].

medicine, research & experimental

Erratum: MiR-30a-5p Suppresses Cell Growth and Enhances Apoptosis of Hepatocellular Carcinoma Cells Via Targeting AEG-1.

Mir-148b Suppresses Cell Proliferation And Invasion In Hepatocellular Carcinoma By Targeting Wnt1/Beta-Catenin Pathway (Vol 5, 8087, 2015)

Erratum: miR-30d inhibits cell biological progression of Ewing's sarcoma by suppressing the MEK/ERK and PI3K/Akt pathways in vitro .

[Corrigendum] MicroRNA‑92a Contributes to Tumor Growth of Human Hepatocellular Carcinoma by Targeting FBXW7

Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.

Correction to: Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro

Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Erratum: CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway: Erratum.

Retraction Notice To: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells

Erratum: Long noncoding RNA LINC01123 promotes the proliferation and invasion of hepatocellular carcinoma cells by modulating the miR-34a-5p/TUFT1 axis: Erratum.

[Corrigendum] miR‐216a‐5p acts as an oncogene in renal cell carcinoma

Erratum: miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis

The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum

Corrigendum: MicroRNA-608 Promotes Apoptosis in Non-Small Cell Lung Cancer Cells Treated With Doxorubicin Through the Inhibition of TFAP4

Correction: Chao Et Al. MicroRNA-22-3p and MicroRNA-149-5p Inhibit Human Hepatocellular Carcinoma Cell Growth and Metastasis Properties by Regulating Methylenetetrahydrofolate Reductase. Curr. Issues Mol. Biol. 2022, 44, 952–962

[Corrigendum] Propofol‐induced HOXA11‐AS promotes proliferation, migration and invasion, but inhibits apoptosis in hepatocellular carcinoma cells by targeting miR‐4458

Erratum: KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p: Erratum.

[Corrigendum] microRNA‐181a‐5p functions as an oncogene in renal cell carcinoma

Retraction: MicroRNA-142-5p Overexpression Inhibits Cell Growth and Induces Apoptosis by Regulating FOXO in Hepatocellular Carcinoma Cells

MiR-30e Suppresses Proliferation of Hepatoma Cells Via Targeting Prolyl 4-Hydroxylase Subunit Alpha-1 (P4HA1) Mrna

[Corrigendum] miR‐199b‐5p serves as a tumor suppressor in renal cell carcinoma